A detailed history of Allspring Global Investments Holdings, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 521 shares of NVCR stock, worth $16,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares
521
Previous 593 12.14%
Holding current value
$16,135
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$15.61 - $23.34 $1,123 - $1,680
-72 Reduced 12.14%
521 $8,000
Q2 2024

Jul 26, 2024

BUY
$11.83 - $24.05 $7,015 - $14,261
593 New
593 $10,000
Q3 2023

Oct 27, 2023

BUY
$16.15 - $42.35 $2,357 - $6,183
146 New
146 $2,000
Q2 2022

Jul 25, 2022

BUY
$56.6 - $89.9 $1,358 - $2,157
24 New
24 $1,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.25B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.